GSA CAPITAL PARTNERS LLP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$595
-25.3%
11,845
-34.8%
0.05%
-48.5%
Q4 2022$796
-99.8%
18,168
+270.2%
0.10%
+94.1%
Q3 2021$505,000
-45.1%
4,908
-53.1%
0.05%
-51.0%
Q2 2021$920,000
+64.9%
10,463
+110.4%
0.10%
+14.3%
Q4 2020$558,000
+76.6%
4,973
+15.6%
0.09%
+111.6%
Q3 2019$316,0004,3010.04%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders